| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/01/2003 | US20030082195 Method of enhancing an immune response |
| 05/01/2003 | US20030082194 Inducting immunology response; anticancer agent |
| 05/01/2003 | US20030082191 Treatment for central nervous system disorders |
| 05/01/2003 | US20030082186 Synthetic peptides that bind to the hepatitis B virus core and E antigens |
| 05/01/2003 | US20030082185 Compositions and methods for inhibition of hiv-1 infection |
| 05/01/2003 | US20030082184 Uses of mammalian cytokine; related reagents |
| 05/01/2003 | US20030082182 Antiinflammatory agents, inflammatory bowel disorders, antiulcer agents |
| 05/01/2003 | US20030082181 Growth differentiation factor-8 |
| 05/01/2003 | US20030082177 Angiopoietins and methods of use thereof |
| 05/01/2003 | US20030082176 Therapy for metabolism disorders |
| 05/01/2003 | US20030082175 April receptor (BCMA) and uses thereof |
| 05/01/2003 | US20030082174 Novel proteins and nucleic acids encoding same |
| 05/01/2003 | US20030082173 Screening drugs that block lymphocytes; genetic engineered rodent |
| 05/01/2003 | US20030082171 Deafness therapy, prevention; mylein protein vaccine |
| 05/01/2003 | US20030082170 Protein from brucella species |
| 05/01/2003 | US20030082166 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 05/01/2003 | US20030082162 Therapy for genetic disorders in humans, animals; polypeptide coding antitrypsin |
| 05/01/2003 | US20030082159 Lentiviral vector-mediated gene transfer and uses thereof |
| 05/01/2003 | US20030082157 Receptor and related products and methods |
| 05/01/2003 | US20030082156 Detecting disease antigen; anticancer agents |
| 05/01/2003 | US20030082150 Recombinant adenoviral vectors for human tumour gene therapy |
| 05/01/2003 | US20030082145 Adeno-associated virus materials and methods |
| 05/01/2003 | US20030082143 Filamentous phage particles having a ligand on surface for delivering a therapeutic gene to a cell; gene therapy |
| 05/01/2003 | US20030082140 Increasing the amount of the cell differentiation associated protein, MDA-7 and decreasing RAS gene activity by administering a viral vector comprising an MDA-7 gene and an antisense ras oligonucleotide; treating pancreatic cancer |
| 05/01/2003 | US20030080056 Extraction of biological components from body fluids |
| 05/01/2003 | CA2842429A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 05/01/2003 | CA2675409A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 05/01/2003 | CA2471532A1 A synthetic chimeric fusion protein with immuno-therapeutic uses |
| 05/01/2003 | CA2470197A1 Mycobacterial genes down-regulated during latency |
| 05/01/2003 | CA2465268A1 Three-dimensional structures of tall-1 and its cognate receptors and modified proteins and methods related thereto |
| 05/01/2003 | CA2464795A1 Thymosin augmentation of genetic immunization |
| 05/01/2003 | CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 05/01/2003 | CA2464417A1 Promoters to control cell differentiation |
| 05/01/2003 | CA2464394A1 Methods and compositions for inducing tumor-specific cytotoxicity |
| 05/01/2003 | CA2464368A1 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments |
| 05/01/2003 | CA2464366A1 A method for identification and development of therapeutic agents |
| 05/01/2003 | CA2464344A1 Ee3-protein family and corresponding dna sequences |
| 05/01/2003 | CA2464338A1 Infectious salmon anaemia virus vaccine |
| 05/01/2003 | CA2464239A1 Psma antibodies and protein multimers |
| 05/01/2003 | CA2463960A1 Transient immortalization |
| 05/01/2003 | CA2463772A1 Thrombin-cleavable chimeric proteins |
| 05/01/2003 | CA2462591A1 Method of presuming domain linker region of protein |
| 05/01/2003 | CA2461665A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 05/01/2003 | CA2461543A1 Sperm factor sequences |
| 05/01/2003 | CA2460665A1 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications |
| 05/01/2003 | CA2457545A1 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor |
| 05/01/2003 | CA2429505A1 Prevention of recurrent viral disease |
| 04/30/2003 | CN1415019A Method for making insulin precursors and insulin precursor analogus having improved fermentation yield in yeast |
| 04/30/2003 | CN1415017A UDP-glucose: aglycon-glacosyltransferase |
| 04/30/2003 | CN1415014A Increased lysine production by gene amplification |
| 04/30/2003 | CN1415013A BASB059 polypeptides from neisseria meningitidis |
| 04/30/2003 | CN1415012A Human proteins binding to human tyrosine kinase HcK and genes encoding the same |
| 04/30/2003 | CN1414976A Chimeric peptides used as immunogen and its antibody, and method for their use for immunization |
| 04/30/2003 | CN1414975A Sex-chromosome-specific proteins, species specific and sperm specific protein and method for their identification and isolation |
| 04/30/2003 | CN1414974A Method for making insulin precursors and insulin precursor analogs |
| 04/30/2003 | CN1414973A Insecticidal proteins from bacillus thuringiensis |
| 04/30/2003 | CN1414972A Method for reducing immunogenicity of heterologous proteins by elimination of T-cell epitopes |
| 04/30/2003 | CN1414970A Transgenically produced fusion proteins |
| 04/30/2003 | CN1414865A 癌症的治疗 Treatment of cancer |
| 04/30/2003 | CN1414102A Binding region of erythrocyte binding protein of Plasmodium vivax and Plasmodium falciform |
| 04/30/2003 | CN1414101A Desmocyte growth factor 11 |
| 04/30/2003 | CN1414100A Desmocyte growth factor 13 |
| 04/30/2003 | CN1414019A Method of producing high purity postmenopause urine promoted gonadofrophin |
| 04/30/2003 | CN1414018A Binding region of erythrocyte binding protein of plasmodium vivax and plasmodium falciform |
| 04/30/2003 | CN1414017A Preparation of anti cytoplasmic thymidine kinase-IgY and tumor diagnosis composition |
| 04/30/2003 | CN1414016A Leptospira adventitial protein, its code sequence and use |
| 04/30/2003 | CN1414015A Leptospira adventitial protein, its code sequence and use |
| 04/30/2003 | CN1414014A Leptospira adventitial protein its code sequence and use |
| 04/30/2003 | CN1107115C System for expression of heterologous antigens as fusion proteins |
| 04/30/2003 | CN1107072C Programing cell death induced molecule II |
| 04/30/2003 | CN1106858C Vaccine composition having antitumour activity and use there of in therapy of malignant diseases |
| 04/30/2003 | CN1106846C Antitumor agent |
| 04/30/2003 | CA2410134A1 Serological assay for neospora caninum |
| 04/29/2003 | US6555734 Modified dihydroflavonol 4-reductase (DFR) nucleic acids;encoding the modified DFR characterized by its ability to reduce dihydrokaempferol preferentially and increase the content of pelargonidin-based pigments |
| 04/29/2003 | US6555693 Compounds that affect the expression of genes essential for the proliferation of the pathogen; promoters or gene expression inhibition; binding to double-stranded DNA; fungicides; bactericides; viricides |
| 04/29/2003 | US6555672 Growth differentiation factor promoter and uses therefor |
| 04/29/2003 | US6555670 Specifically expressed in haploid cells of the testis, located on the X-chromosome of a mammal; given nucleotide sequence; homologous to the drosophila gcl gene |
| 04/29/2003 | US6555667 Hypoxia-regulated genes |
| 04/29/2003 | US6555666 Transcripts encoding immunomodulatory polypeptides |
| 04/29/2003 | US6555661 Simple, environmentally benign, method for purifying protein A |
| 04/29/2003 | US6555660 A polypeptide having an amino acid sequence that differs from the preferred granulocyate colony stimulating factor sequence in no more than 15 amino acid residues, and a nonpeptide polymer attached to the amino acid of above polypeptide |
| 04/29/2003 | US6555659 Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5% w/w |
| 04/29/2003 | US6555658 A novel human cytokine which can induce production of gamma-interferon in vitro in human peripheral blood lymphocytes; use treating cancer, infections such as AIDS (acquired immune deficiency syndrome) |
| 04/29/2003 | US6555657 Isolated transcription factor for an alpha-amylase promoter in filamentous fungi |
| 04/29/2003 | US6555656 Covalent modification of abnormal prion protein |
| 04/29/2003 | US6555655 Novel insecticidal polypeptides of given amino acid sequence obtained by culturing Bacillus thuringiensis NRRL B-21915 or NRRL B-21916 cells |
| 04/29/2003 | US6555654 Low-density lipoprotein (LDL)-receptor related protein-3 (LRP-3); encoding nucleic acid; the gene is associated with type 1 diabetes (insulin dependent diabetes mellitus (IDDM); indications are it is the IDDM susceptibility gene IDDM4 |
| 04/29/2003 | US6555653 Compounds for diagnosis of tuberculosis and methods for their use |
| 04/29/2003 | US6555652 Tumor antigen peptide derivatives |
| 04/29/2003 | US6555651 Ligand binding site of rage and uses thereof |
| 04/29/2003 | US6555570 Growth hormone secretagogous with improved bioavailability |
| 04/29/2003 | US6555566 Methods and materials for treating and preventing inflammation of mucosal tissue |
| 04/29/2003 | US6555522 Peptides and other small molecules derived from regions of interacting proteins and uses thereof |
| 04/29/2003 | US6555521 From a crystallization solution comprising a GLP, a buffering agent, an alcohol or a mono or disaccharide, and optionally, ammonium sulfate or zinc. |
| 04/29/2003 | US6555520 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and immunologicval disorders |
| 04/29/2003 | US6555373 Methods for identifying human cell lines useful for endogenous gene activation isolated human cell lines identified thereby, and uses thereof |
| 04/29/2003 | US6555369 Inducing nucleotide sequence biosynthesis in cells of nervous system; obtain vector coding preferential genes, transfect cells of nervous system, monitor cell for preferential expression |
| 04/29/2003 | US6555368 Single-chain antibody introduced into the minor capsid proteins so that the adenoviral vector can be targeted to a particular cell type |
| 04/29/2003 | US6555347 Human minor vault protein p193 |
| 04/29/2003 | US6555346 Selecting a recombinant baculovirus expressing the protein, growing insect cells in a culture vessel and infecting the cells with an inoculum of baculovirus at a cell density of 1 x 105-5 x 106 cells/ml |